Bezafibrate improves mitochondrial function, blood-brain barrier integrity, and social deficits in models of 22q11.2 deletion syndrome | Science Translational Medicine
Pharmacological recovery of mitochondrial function improves blood-brain barrier function and cognition in 22q11.2 deletion syndrome, a risk factor for schizophrenia.
